Phase 2b VANTAGE PBC study highlighting improvements in itch and fatigue will be presented at EASL – Data from Mirum studies ...

Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced eight abstracts have ...

Meadows will be the first biome you'll encounter after departing from Lumiere in Clair Obscur: Expedition 33's prologue.

Once you reach the ground, go near the glowing crystal and strike it to obtain one of three Lustrous Rocks for Hexga in Clair Obscur: Expedition 33. From the first Rock move forward and take the left ...

NAVI Junior has been making waves within the Dota 2 esports community with an impressive run at the ongoing PGL Wallachia ...

I got to play Mario Kart World at the Nintendo Switch 2 Experience in Los Angeles last week, and after just an hour behind ...

The 160-team ALGS Open is almost here. The ALGS Open is almost here. This is set to be the biggest LAN in ALGS history, with a different format, more teams than ever before and direct spots at the ...

Alagille syndrome (ALGS) and progressive familial intrahepatic cholestasis (PFIC). Ipsen is currently not running studies of odevixibat in PBC, but has a phase 3 programme on the go in biliary ...

The FDA has approved a tablet form of Livmarli (maralixibat) for cholestatic pruritus in patients with Alagille syndrome and progressive familial intrahepatic cholestasis.